Smartlab Europe

News

Aptar Pharma to Exhibit Innovative Drug Delivery Devices at Pharmapack 2018 in Paris, France

Aptar Pharma, a leading drug delivery systems provider, will once again bea key exhibitor at Pharmapack 2018, Europe's dedicated pharmaceutical packaging and drug delivery event, which takes place on February 7-8 at Paris Expo, Porte de Versailles, France. ...

CPhI-P-MEC India Expo 2017 Catapults the Pharma Sector to New Heights

UBM India celebrates the industry with a dazzling array of comprehensive, path-breaking events under the India Pharma Week umbrella. South Asia’s largest pharma event at a glance: 1550+ exhibitors An increase of 20 per cent...

Major changes for bio supply forecast in 2018 by bioLIVE

Industry experts from bioLIVE – the new UBM biomanufacturing and bioprocessing event taking place next year in Madrid (October 9-11). Predict that 2018 will usher in a new age of increased integration and collaboration across the...

BioGenes Establishes Scientific Advisory Board

BioGenes GmbH, specializing in ELISA development and production and a global leader in host cell protein (HCP) assay development, today announces the establishment of a Scientific Advisory Board which includes the following four renowned experts: ...

Saneca Pharma strengthens team with new sales director

Slovakia-based contract development and manufacturing organization (CDMO) Saneca Pharma has strengthened its team with the appointment of a new CDMO sales director as it continues to implement its global growth strategy.With nearly 30 years’ experience in the industry, having...

Vetter Receives Corporate Health Award’s Recognition of Excellence

In addition to being a leading global contract development and manufacturing organization, Vetter is also a leader in the area of occupational health management. That is the conclusion reached by the initiative Corporate Health Award, which...

Agendia and UZ Leuven Partner to Co-Validate MammaPrint® BluePrint® Breast Cancer Risk of Recurrence and Molecular Subtyping Kit Ahead of European Launch

Agendia, a world leader in personalized medicine and molecular cancer diagnostics, and University Hospitals Leuven (UZ Leuven) in Belgium have partnered to co-validate Agendia’s new in vitro diagnostic (IVD) MammaPrint® BluePrint® Breast Cancer Risk of Recurrence and Molecular Subtyping...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »